2026 NPPES data Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician NPI 1114964202 M.D.
Verify on CMS →

LAWRENCE LIN, M.D.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician in THOUSAND OAKS, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 403 beneficiaries · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician avg: 611
MIPS score
90.0784/100
▲ 7 pts above national avg 83.1 · [object Object]
Industry payments
$99.99
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

LAWRENCE LIN, M.D. reported a CMS MIPS final score of 90.0784/100 — above the 83.1 national average — and filed 1,219 Medicare Part D claims in 2023.

90.0784/100
MIPS score · +7 vs avg
1K
Part D claims, 2023
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

LAWRENCE LIN, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

90 Top 40% higher than 60% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

LAWRENCE LIN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about LAWRENCE LIN, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 05/31/2006

NPI 1114964202

Primary specialty

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician

Niche

568 US NPIs in this specialty

Medicare Part D claims

1,219 100% vs specialty avg

2023 prescription claims

Specialty avg: 611

MIPS final score

90.0784/100 6.978400000000008% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in California

How Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician compares to other specialties among California providers

California providers

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician share within California

1. Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician share within California

Medicare quality performance — MIPS

LAWRENCE LIN, M.D.'s 2023 MIPS final score plotted against the Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician national average

High performer (top quartile)
MIPS Final Score
90.0784/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician) — 90.0784/100 vs national avg 83.1

0%100%National avg83%90.1%
MIPS final score (Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician) — 90.0784/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LAWRENCE LIN, M.D. is a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider practicing in THOUSAND OAKS, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1114964202. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

LAWRENCE LIN, M.D. appears in the CMS NPPES registry as a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider holding M.D. credentials at 1000 NEWBURY RD STE 165, THOUSAND OAKS, CA, 91320, with a listed phone of (805) 449-1778. NPI 1114964202 was issued on 05/31/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,219 prescription claims written by this provider, covering 403 Medicare beneficiaries and totaling roughly $110K in drug spend, with an opioid prescribing rate of 5.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 90.0784/100 for the 2023 performance year (Quality 83.0517), compared with the national average of 83.1.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician is a narrow specialty nationwide, with 568 enrolled providers across 49 states and an average of 611 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1000 NEWBURY RD STE 165
THOUSAND OAKS, CA 91320

Provider Details

NPI 1114964202
Specialty Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
Credentials M.D.
Gender Male
NPI Issued 05/31/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

90.0784
Final Score
Avg: 83.1
83.0517
Quality
98
Promoting Interoperability

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for LAWRENCE LIN, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$100

Largest payer

Astellas Pharma US Inc

Most common payment type

Education

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to LAWRENCE LIN, M.D.. To verify LAWRENCE LIN, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,219
Total Claims
$110K
Total Drug Cost
403
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,099
Total Day Supply
49,001
Generic Drug Cost
$39K
Opioid Claims
69 (5.7% rate)
Antibiotic Claims
398

Patient Demographics

Average Patient Age
76.3 years
Avg HCC Risk Score
1.08

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Oxybutynin Chloride Er
Oxybutynin Chloride
147
Ciprofloxacin Hcl
104
Nitrofurantoin Mono-Macro
Nitrofurantoin Monohyd/M-Cryst
101
Ibuprofen
70
Bethanechol Chloride
69
Fluconazole
69
Methenamine Hippurate
66
Estradiol
60
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
53
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
49

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Overview

How LAWRENCE LIN, M.D. fits within the Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician landscape nationally.

568
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in US
49
States with Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
611
Avg Claims per Provider

LAWRENCE LIN, M.D.'s 1,219 claims are above the specialty average of 611.

Nearby Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as LIN.

Compare Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is LAWRENCE LIN, M.D.'s specialty?
LAWRENCE LIN, M.D. specializes in Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician and practices in THOUSAND OAKS, California. Credentials: M.D..
How much does LAWRENCE LIN, M.D. prescribe under Medicare Part D?
In 2023, LAWRENCE LIN, M.D. wrote 1,219 Medicare Part D claims totaling $110K in drug costs for 403 beneficiaries.
What is LAWRENCE LIN, M.D.'s Medicare quality score?
LAWRENCE LIN, M.D. has a CMS MIPS Final Score of 90.0784/100 (Quality: 83.0517). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is LAWRENCE LIN, M.D. located?
LAWRENCE LIN, M.D. is located at 1000 NEWBURY RD STE 165, THOUSAND OAKS, CA, 91320. Phone: (805) 449-1778.
What is LAWRENCE LIN, M.D.'s NPI number?
LAWRENCE LIN, M.D.'s National Provider Identifier (NPI) is 1114964202, issued on 05/31/2006.
Does LAWRENCE LIN, M.D. prescribe opioids?
Yes, LAWRENCE LIN, M.D. had 69 opioid claims in 2023 with an opioid prescribing rate of 5.7%.
How many Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers are there in the US?
There are 568 Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers across 49 states in the US. The average Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider writes 611 Medicare Part D claims per year.
What drugs does LAWRENCE LIN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, LAWRENCE LIN, M.D.'s most frequently prescribed drugs include Oxybutynin Chloride Er, Ciprofloxacin Hcl, Nitrofurantoin Mono-Macro. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LAWRENCE LIN, M.D. accept Medicare?
LAWRENCE LIN, M.D. appears in CMS Medicare data with 1,219 Part D claims and 403 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LAWRENCE LIN, M.D.'s credentials?
LAWRENCE LIN, M.D.'s NPI is 1114964202 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology